5AM Partners VII, LLC, 10% Owner at Skye Bioscience, Inc. (SKYE), sold 375,840 shares at $0.38 ($140K) on 2026-08-18, disclosed to the SEC on 2026-08-20.
Open-market sale of $140k SKYE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.38 | 1,830 | $695 | 0.5% |
| 2 | $0.38 | 45,090 | $17K | 12.2% |
| 3 | $0.38 | 253,080 | $96K | 68.5% |
| 4 | $0.35 | 409 | $143 | 0.1% |
| 5 | $0.35 | 10,255 | $4K | 2.6% |
| 6 | $0.35 | 57,476 |
| $20K |
| 14.3% |
| 7 | $0.32 | 46 | $15 | 0.0% |
| 8 | $0.32 | 1,159 | $371 | 0.3% |
| 9 | $0.32 | 6,495 | $2K | 1.5% |
| Total | $0.37 avg | 375,840 | $140K | 100% |